sunitinib, optionally in the form of a pharmaceutically acceptable salt, and the salt l-malate (capsules)

• 收藏
• 分享

专利权人:

Sugen Inc.;Pharmacia & Upjohn Company LLC

发明人:

WEI Chung, Chen,SUN Li,TANG Peng, Cho,MILLER Todd,LI Xiaoyuan,HAWLEY Michael,SHIRAZIAN Shahrzad,LIANG Congxin,VOJKOVSKY Tomas,NEMATALLA Asaad, S.

申请号：

LU91407

公开号：

LU91407I9

申请日:

2008.01.09

申请国别(地区):

LU

年份:

2018

代理人:

摘要：

The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/